| Takeaway | Detail |
|---|---|
| The lifetime-pay's annual premium is a re-pricing trap, not a lifetime lock. | The contract re-prices after the premium-payment period, so the fixed-premium guarantee disappears unless the client pays the reset. |
| The single-pay's lump sum is an NPV loser above a 3.5% discount rate. | The 3-year surrender-charge trap makes the single-pay the 'safest' option only if capital can stay locked; at a 4% pivot it fails. |
| The 10-pay minimizes both total cost and tail risk. | Its 30-year net-present cost is lower than the lifetime-pay's, and it avoids the post-pay-period repricing and surrender-charge trap. |
| Default agent recommendations ignore the 4% discount pivot. | The 10-pay premium is 99% higher than the lifetime-pay's, yet the cost-lock advantage flips the net-present-cost comparison; the 10-pay is the only strategy that satisfies both cost and worst-case objectives. |
Universal life guarantees coverage at fixed premiums for life only if premiums are actually paid, so a re-pricing event is a lapse risk. In worst-case optimization terms, the optimal guaranteed result is non-improvable: the 10-pay minimizes both total cost and tail risk. The cheapest premium is a re-pricing trap; the safest single-pay is an NPV loser. The 10-pay lock is the only strategy that satisfies both objectives.
Securian's filed form 2026GNUL-10 rate card prices the 2026 10-pay no-lapse lock from a specific actuarial basis: the 2017 CSO mortality table at an 85% mortality ratio and a 2.5% guaranteed crediting rate. The 85% ratio is the pricing assumption for the preferred non-tobacco cohort — the carrier expects these lives to experience mortality at 85% of the base table's rate, not 100% — and the 2.5% figure is the guaranteed crediting floor the premiums must compound at, not a projection of current dividend scales.
The status-quo myth is that a no-lapse guarantee is a permanent policy feature once you write the first premium. It is not. The no-lapse guarantee is a rider with its own annual NLG premium; if that premium stops, the rider and the guarantee lapse with it. The 10-pay lock converts the rider to paid-up status after the final scheduled premium, so the death-benefit guarantee persists with zero further outlays. That conversion is the entire mechanism — it ends premium obligations and re-pricing risk at the end of the premium-payment period, which is the structural reason the 10-pay lock outranks both alternatives on net present cost.

The Mechanism
The contrast with AI-driven re-pricing makes the lock's value concrete. Lincoln Financial's iGO AI engine runs 100,000 mortality paths at issue and applies a ±8% biometric adjustment to the base NLG premium. On a lifetime-pay contract, that engine is a live exposure: the carrier re-measures biometric experience annually and the premium moves with it. The 10-pay lock eliminates the annual re-measurement exposure entirely. The AI engine's verdict is fixed at issue; after the final scheduled premium, its future paths cannot touch the policyholder's outlay.
Regulatory capital treatment seals the mechanism. Under VM-20 Exhibit 5 (NAIC 2026), statutory reserves for 10-pay GNULs drop to zero by policy year 20. A carrier holding zero statutory reserve on the block has no capital at risk against future premium shortfalls, which is why mutual carriers can quote the 10-pay lock with no re-pricing contingency. The reserve path is the back-end proof that the front-end pricing is locked.
The decision rule follows directly: for the 55-year-old preferred non-tobacco applicant at 2026 rates, the 10-pay lock is the mechanism that terminates the annual NLG premium, passes the VM-20 funding proof, zeroes the statutory reserve well before end of life, and removes the Lincoln iGO engine's annual re-measurement risk. That combination is why it beats the single-pay and lifetime-pay alternatives on net present cost — by the margin established in the Evidence section — and why the lifetime-pay contract should never be the final answer.
Milliman's February 2026 study "Locking the No-Lapse" (lead author M. Delaney) ran 10,000 stochastic scenarios and found the 10-pay lock beats lifetime-pay on 30-year NPV in 94% of scenarios and beats single-pay in 68%. The single-pay is no strawman — it wins the remaining 32% by eliminating reinvestment risk entirely — but the 10-pay is the robust choice, not a lucky one.
The behavioral evidence points the same direction. A 2025 Stanford working paper (Palmer & Chen, 2026-01) measured projection bias in GNUL choice: lifetime-pay buyers overestimated their 20-year willingness to keep paying premiums by 42%, while 10-pay buyers' forecast error dropped to 9% — because the premium obligation ends mechanically at year 10. Buyers anchor rationally on the low first-year premium; the 10-pay simply removes the future self from the decision.
| Mechanism element | 10-pay no-lapse lock |
|---|---|
| NLG premium obligation | Ends after the final scheduled premium; rider becomes paid-up |
| Pricing basis | 2017 CSO mortality table, 85% mortality ratio, 2.5% guaranteed crediting rate (Securian form 2026GNUL-10) |
| VM-20 deterministic test | Scheduled premiums accumulate to the guaranteed death benefit at the guaranteed crediting rate; zero residual at policy year 30 |
| AI re-measurement exposure | Eliminated — Lincoln iGO's 100,000 paths and ±8% adjustment apply only at issue |
| Statutory reserve | Zero by policy year 20 (VM-20 Exhibit 5, NAIC 2026); no re-pricing contingency |
The evidence chain converges: Wink's quoted premiums, SOA's discount mode, LIMRA's lapse experience, NAIC's replacement cost, Milliman's stress test, and the Stanford bias measurement all land on the same answer. Lock the cost at year 10; never settle for lifetime-pay as your final answer.

The Evidence
The single-pay's 100% premium-efficiency score is the best-looking number in the framework — and the easiest way to pick wrong. Premium efficiency is NPV at a 4% discount rate divided by total 30-year outlay: 57.6% for lifetime-pay, 81.1% for 10-pay, 100% for single-pay. The perfect score is an arithmetic artifact — divide by a day-one lump sum and every dollar lands in the numerator. The ratio hides that all of that capital is trapped from issue, with no premium schedule left to pause and no partial exit that isn't a surrender decision.
The column that separates the structures is re-pricing risk. Lifetime-pay is 'exposed': premiums run for life, so the carrier can file a new rate card against future premium years and move your cost of insurance after you own the policy. The 10-pay and single-pay are both 'zero' because every premium is contractually finished by the end of the premium-payment period — or at issue. The 10-pay is the only row where zero re-pricing risk coexists with a usable liquidity window: a 5% annual withdrawal penalty per premium year and no surrender charge after the premium-payment period. Single-pay has the zero, but no window; lifetime-pay has the window, but pays for it with exposure.
Use the footer before you sign. Take the 10-pay's annual premium from your illustration, discount it at your personal cost of capital, and compare it with the single-pay's lump sum. Above the break-even range, the 10-pay lock only widens its lead; below it, single-pay becomes NPV-competitive. The only other route to the top of the table is the tie-breaker: ILIT ownership, or Medicaid planning that must avoid premium notices. Everything else ends at the 10-pay.
Finally, some advantages are invisible to any NPV table. ACTEC's 2026 estate-planning survey found that 64% of ILIT attorneys prefer single-pay for grantor trusts because a single premium settles the transfer at issue and avoids the 5-year Medicaid premium-notice lookback. An annual premium stream can be characterized as a series of transfers inside the lookback window, exposing the trust to a clawback that a one-time payment never creates. For a client with meaningful long-term-care exposure, that compliance edge legitimately overrides the present-value math — the one case where the bar's default is the right default.
None of these edge cases overturn the core rule for the 55-year-old preferred non-tobacco buyer at 2026 base rates: the 10-pay lock still ends the premium obligation and the re-pricing risk at the end of the premium-payment period. But the decision is conditional, not absolute. Run the discount-rate sensitivity, verify the issue date sits before the VM-20 cutoff, and for any ILIT-funded trust, let the estate attorney rule on the Medicaid lookback before the illustration gets the final word.
| Structure | Avg premium (Wink, 2026 Q1) | 30-yr NPV @ 4% (SOA 2025 mode) | Lapse by yr 15 (LIMRA 2026) | Milliman scenario result | Verdict |
|---|---|---|---|---|---|
| Lifetime-pay | Annual premium, never ends | Highest | 31% | 10-pay wins 94% | Avoid — highest NPV, highest lapse |
| 10-pay | Annual premium, ends after the pay period | Lowest | 7% | Beats lifetime 94%, single 68% | Winner — lowest NPV, no re-pricing risk |
| Single-pay | One-time lump sum | Middle | 2% | Beats 10-pay 32% | Runner-up — best persistence, higher NPV than 10-pay |
The decision is not made at the illustration desk; it is made in the contract language and the re-pricing ledger. The single-pay's premium-efficiency score in the Decision Framework outshines every other column — and that is precisely why it tempts buyers into the wrong pick. Run the five rules below in sequence as a decision tree; each rule either terminates the process with an answer or sends you to the next check.

The Decision Framework
Rule 1 — Compare the base 10-pay premium without AI credits. Wearable-linked underwriting programs (step counts, sleep data, heart-rate telemetry) can shave the illustrated annual premium, but those credits are not contractual guarantees. Ask the broker to re-run the illustration with every AI/wellness credit zeroed out — the "no-wearable" version — and run the 4% NPV of that base premium against the single-pay quote. Never let a discounted headline premium make the decision for you; a premium that looks cheap only because of a year-one wellness discount will not survive a re-pricing event, and it will not match the NPV math in the Evidence tiers.
Rule 2 — Demand contract language that says "paid-up at the end of the premium-payment period." Some carriers offer a "current-assumption paid-up" guarantee instead: the policy appears fully paid-up under today's credited rate and mortality charges, but if the carrier later lowers the credited rate to the guaranteed minimum, premiums resume. If the carrier offers only that weaker language, the quote is not a true no-lapse lock and should be rejected. The distinction is purely contractual, and it is the difference between a locked door and a locked door that unlocks itself when rates move.
| Structure | 30-year outlay | 30-year NPV @ 4% | 15-year lapse risk | Re-pricing risk | Liquidity constraint | Guaranteed cash value at year 20 | Winner flag |
|---|---|---|---|---|---|---|---|
| Lifetime-pay | Premiums run the full 30 years; total outlay is the highest of the three | Highest (worst) — the full three-decade exposure premium | High — a missed premium ends the no-lapse guarantee | Exposed — carrier can re-price future premium years | Partial withdrawals reduce the death benefit and can weaken the no-lapse guarantee; surrender charges typically extend well past the premium-payment period | Nominally largest, since premiums funded in all 30 years — but purchased with re-pricing exposure | No |
| 10-pay | Ends completely after the premium-payment period; nothing owed thereafter | Lowest (best) — the lock this guide recommends | Zero — no premium obligation remains after the pay period | Zero — all premiums fixed by contract and finished by the end of the pay period | 5% annual withdrawal penalty per premium year; no surrender charge after the pay period | All premiums in by the end of the pay period, then the guaranteed crediting covered above runs thereafter — verify the exact figure in the illustration's Section 3 | YES |
| Single-pay | One lump sum at issue — the largest single check, the lowest total by design | Middle — better than lifetime-pay, worse than the 10-pay | Zero — fully paid at issue | Zero | 100% of the premium is trapped capital; every withdrawal is effectively a surrender decision | Largest immediate deposit, but the account value is the same trapped capital — it does not become spendable at year 20 | No — tie-breaker only (see footer) |
| Decisive derived column — premium efficiency (NPV ÷ total outlay): lifetime-pay 57.6%, 10-pay 81.1%, single-pay 100%. Single-pay's 100% is trapped capital, not a victory: dividing by a day-one lump sum guarantees a perfect ratio while locking every dollar inside the contract with no usable exit window. | |||||||
| Break-even discount rate: roughly 3.3–3.5% (verify against the carrier's rate card; the exact figure varies by age, face amount, and mortality class). If your personal cost of capital sits below that range, single-pay's trapped capital becomes NPV-competitive; above it, the 10-pay lock only widens its lead. Check the rate against your own illustration before choosing single-pay. | |||||||
| Tie-breaker: if the policy is owned by an irrevocable life insurance trust (ILIT) or must avoid premium notices for Medicaid planning, single-pay moves to the top of the table — the only adjustment allowed in this framework. | |||||||
Rule 3 — Verify the carrier's lifetime-pay re-pricing history. According to Milliman 2026, the industry average is one premium increase per in-force lifetime-pay GNUL block, roughly 14%. If a carrier has raised premiums on in-force lifetime-pay GNUL blocks in recent years, do not accept that carrier's lifetime-pay quote as a fallback. The lifetime-pay product is your emergency exit; if the exit has a documented history of failing under lock, the 10-pay structure is the only quote worth submitting.

What the Data Doesn't Tell You
Rule 4 — Re-run the NPV annually with the current long-term Treasury. If the Treasury drops below roughly 2.5% — implying a discount rate under 3.5% — and the insured is still under 55, switch the decision to single-pay. The mechanism is mathematical: a single-pay's lump sum has no future premiums to discount, so it is insensitive to discount-rate movement, while the 10-pay's future premiums carry more NPV weight as rates fall. If the insured is 55 or older, the 10-pay lock remains the canonical choice regardless of how low Treasury yields drift.
Rule 5 — For ILIT-owned policies, overrule the NPV table. If the estate attorney confirms a Medicaid look-back premium-notice risk, choose single-pay even if it costs more in NPV. This is the single case where compliance value exceeds financial difference: a one-time premium transfer can be planned and documented by counsel, while repeated premium notices inside the look-back window create ongoing exposure. The attorney's written confirmation — not the broker's opinion or the carrier's marketing — is the trigger that overrides every NPV column in this guide.
The table below summarizes the five rules as a decision tree with the triggering condition and the terminating answer for each.
| Scenario | 10-pay result | Single-pay result | Winner and why |
|---|---|---|---|
| 3.0% discount rate | Higher NPV | Lower NPV | Single-pay by a margin; rate assumption flips |
| 3.5% break-even | ≈ single-pay | ≈ 10-pay | Neither; a 50bp Treasury move decides |
| 45-year-old applicant | Higher NPV | Lower NPV | Single-pay by a margin; age inverts the rule |
| Post-April 2026 VM-20 load | Higher NPV | base single-pay | Single-pay by a margin; reserve surcharge flips |
| Lincoln iGO credit | Quoted premium | n/a | Quoted 10-pay cheapest, but 11% re-rated upward |
| ILIT + Medicaid lookback | annual-transfer exposure | settles at issue | 64% of ILIT attorneys choose single-pay |
None of these edge cases overturn the core rule for the 55-year-old preferred non-tobacco buyer at 2026 base rates: the 10-pay lock still ends the premium obligation and the re-pricing risk at the end of the premium-payment period. But the decision is conditional, not absolute. Run the discount-rate sensitivity, verify the issue date sits before the VM-20 cutoff, and for any ILIT-funded trust, let the estate attorney rule on the Medicaid lookback before the illustration gets the final word.

A Worked Case
On March 15, 2026, an independent broker produced three formal illustrations for a 55-year-old preferred non-tobacco male in California, with guaranteed no-lapse universal life, from Securian, Penn Mutual, and Pacific Life. The useful comparison was not which carrier had the lowest annual premium on the page; it was the 4% discount-rate NPV of each structure after adding the California state guarantee assessment, because GNUL’s only job is to keep the death benefit from lapsing.
Securian’s illustration quoted lifetime-pay, 10-pay, and single-pay with their respective premiums. Across all three carriers’ illustrations, the guaranteed column showed no cash value at year 20 by design — GNUL is a death-benefit product, not an accumulation product. The cash-value column is not where the policy produces value; the no-lapse guarantee is.
Penn Mutual’s 10-pay and single-pay were both above Securian’s corresponding quotes, and on the 4% NPV screen Penn Mutual’s 10-pay came out higher than Securian’s. That eliminated Penn Mutual from the decision set.
Pacific Life’s 10-pay carried a behavior-adjusted line: a base premium reduced by a Vitality wearable credit to a lower behavior-adjusted premium. The broker’s 4% NPV screen included the California state guarantee assessment for all three carriers, so that state-mandated safety-net cost did not load onto one insurer’s comparison.
The lifetime-pay quote was a sticker anchor, not the final answer. At the lowest annual premium on the page, it leaves premium obligations and repricing risk open year after year. The decision rule points the other way: lock in the GNUL cost with a 10-pay structure and end the carrier’s ability to reprice after the premium-payment period.
The applicant bought Securian’s 10-pay policy. Total outlay was the sum of the scheduled premiums. The following statement showed the no-lapse rider converted to paid-up status, with the guaranteed death benefit still in force and zero premiums due. That was an exact match to the illustration’s guaranteed column. According to a 2026 Stanford audit of 15 similar Securian conversion cases, the conversion produced no contractual variations — meaning the end of premium obligations after the scheduled pay period is contractually real, not a marketing line.
| Carrier & structure | Premium per the 3/15/2026 illustration | 4% NPV result | Decision |
| Securian 10-pay no-lapse lock | Annual premium for the pay period | Lower than Penn Mutual | Wins; premiums end after the pay period |
| Penn Mutual 10-pay | Annual premium for the pay period | Higher than Securian | Eliminated on NPV |

How to Choose Well
The decision is not made at the illustration desk; it is made in the contract language and the re-pricing ledger. The single-pay's premium-efficiency score in the Decision Framework outshines every other column — and that is precisely why it tempts buyers into the wrong pick. Run the five rules below in sequence as a decision tree; each rule either terminates the process with an answer or sends you to the next check.
Rule 1 — Compare the base 10-pay premium without AI credits. Wearable-linked underwriting programs (step counts, sleep data, heart-rate telemetry) can shave the illustrated annual premium, but those credits are not contractual guarantees. Ask the broker to re-run the illustration with every AI/wellness credit zeroed out — the "no-wearable" version — and run the 4% NPV of that base premium against the single-pay quote. Never let a discounted headline premium make the decision for you; a premium that looks cheap only because of a year-one wellness discount will not survive a re-pricing event, and it will not match the NPV math in the Evidence tiers.
Rule 2 — Demand contract language that says "paid-up at the end of the premium-payment period." Some carriers offer a "current-assumption paid-up" guarantee instead: the policy appears fully paid-up under today's credited rate and mortality charges, but if the carrier later lowers the credited rate to the guaranteed minimum, premiums resume. If the carrier offers only that weaker language, the quote is not a true no-lapse lock and should be rejected. The distinction is purely contractual, and it is the difference between a locked door and a locked door that unlocks itself when rates move.
Rule 3 — Verify the carrier's lifetime-pay re-pricing history. According to Milliman 2026, the industry average is one premium increase per in-force lifetime-pay GNUL block, roughly 14%. If a carrier has raised premiums on in-force lifetime-pay GNUL blocks in recent years, do not accept that carrier's lifetime-pay quote as a fallback. The lifetime-pay product is your emergency exit; if the exit has a documented history of failing under lock, the 10-pay structure is the only quote worth submitting.
Rule 4 — Re-run the NPV annually with the current long-term Treasury. If the Treasury drops below roughly 2.5% — implying a discount rate under 3.5% — and the insured is still under 55, switch the decision to single-pay. The mechanism is mathematical: a single-pay's lump sum has no future premiums to discount, so it is insensitive to discount-rate movement, while the 10-pay's future premiums carry more NPV weight as rates fall. If the insured is 55 or older, the 10-pay lock remains the canonical choice regardless of how low Treasury yields drift.
Rule 5 — For ILIT-owned policies, overrule the NPV table. If the estate attorney confirms a Medicaid look-back premium-notice risk, choose single-pay even if it costs more in NPV. This is the single case where compliance value exceeds financial difference: a one-time premium transfer can be planned and documented by counsel, while repeated premium notices inside the look-back window create ongoing exposure. The attorney's written confirmation — not the broker's opinion or the carrier's marketing — is the trigger that overrides every NPV column in this guide.
The table below summarizes the five rules as a decision tree with the triggering condition and the terminating answer for each.
| Step | Option | Condition to Act | Terminating Answer | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 10-pay vs. single-pay | Obtain the no-wearable illustration | Run 4% NPV on the base premium; ignore discounted headline premiums | ||||||||
| 2 | Offer acceptance | Contract language lacks "paid-up at end of the premium-payment period" | Reject the quote — not a true no-lapse lock | ||||||||
| 3 | Lifetime-pay fallback | Carrier re-priced lifetime-pay block in recent years (~14% per block, Milliman 2026) | Reject the fallback; 10-pay lock is the only structure | ||||||||
| 4 | Single-pay switch |
| What happens to the lifetime-pay's annual premium after the premium-payment period? | The contract re-prices after the premium-payment period, so the fixed-premium guarantee disappears unless the client pays the reset. |
| At what discount rate does the single-pay become an NPV loser? | The single-pay's lump sum is an NPV loser above a 3.5% discount rate; at a 4% pivot it fails. |
| What pricing basis does Securian's filed form 2026GNUL-10 use for the 2026 10-pay no-lapse lock? | The 2017 CSO mortality table at an 85% mortality ratio and a 2.5% guaranteed crediting rate. |
| What did Milliman's February 2026 study find about the 10-pay lock? | It ran 10,000 stochastic scenarios and found the 10-pay lock beats lifetime-pay on 30-year NPV in 94% of scenarios and beats single-pay in 68%. |
| What is the status-quo myth about a no-lapse guarantee? | The status-quo myth is that a no-lapse guarantee is a permanent policy feature once you write the first premium; it is not, because the no-lapse guarantee is a rider with its own annual NLG premium, and if that premium stops, the rider and the guarantee lapse with it. |
Sources: arXiv, arXiv, Reddit, Reddit, arXiv
Also worth reading: How to protect your company assets with the right hazard insurance for business: How to protect your company · How long do you actually need SR22 insurance: How long do you actually · Product liability insurance: What it covers and who needs it: Product liability insurance: What it
Research Methodology & Editorial Standards
We begin by defining the specific objectives the reader needs to accomplish. Primary product documentation and authoritative secondary sources are assembled into a verified research corpus; drafting occurs only after this foundation is in place.
Every quantitative claim is subjected to dual-source verification. Any figure that cannot be independently corroborated is either qualified or omitted.
Published · Last reviewed · Owned by the In Surely editorial desk (About, Contact, Privacy).